Chengdu Maikekang BioTechnology Co., Ltd.
MaxHealth迈科康
Chengdu Maikekang BioTechnology Co., Ltd.
Biotech/Healthcare
Maxvax is focused on developing innovative vaccines and novel adjuvants. The company has advanced proprietary platforms for innovative adjuvants and recombinant protein expression.
Latest round: Series D (2025)
Source: ChinaBulls — chinabulls.com
Last updated 2025-10-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.